FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056411 [Registered on: 11/08/2023] Trial Registered Prospectively
Last Modified On: 10/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   To Study The Predictors of Lymphedema in Ipsilateral Arm in Patients treated with Modified Radical Mastectomy for Breast Cancer  
Scientific Title of Study   To Study The Predictors of Lymphedema in Ipsilateral Arm in Patients treated with Modified Radical Mastectomy for Breast Cancer -A Prospective observational study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  MOHD OZAIR KHAN 
Designation  JUNIOR RESIDENT 
Affiliation  AIIMS RISHIKESH 
Address  Department of General Surgery, AIIMS Rishikesh, Virbhadra Marg, Rishikesh , India

Dehradun
UTTARANCHAL
249203
India 
Phone  7017662384  
Fax    
Email  ozairkhan321@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Farhanul Huda 
Designation  Additional Professor  
Affiliation  AIIMS RISHIKESH 
Address  DEPARTMENT OF GENERAL SURGERY, AIIMS RISHIKESH, VIRBHADRA MARG, RISHIKESH, INDIA


UTTARANCHAL
249203
India 
Phone  9997533211  
Fax    
Email  farhanul1973huda@gmail.com  
 
Details of Contact Person
Public Query
 
Name  MOHD OZAIR KHAN 
Designation  JUNIOR RESIDENT 
Affiliation  AIIMS RISHIKESH 
Address  DEPARTMENT OF GENERAL SURGERY, AIIMS RISHIKESH, VIRBHADRA MARG, RISHIKESH, INDIA


UTTARANCHAL
249203
India 
Phone  7017662384  
Fax    
Email  ozairkhan321@gmail.com  
 
Source of Monetary or Material Support  
Department of general surgery, AIIMS rishikesh , for infrastructural support 
 
Primary Sponsor  
Name  AIIMS RISHIKESH 
Address  DEPARTMENT OF GENERAL SURGERY, AIIMS RISHIKESH, VIRBHADRA MARG, RISHIKESH, INDIA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MOHD OZAIR KHAN  AIIMS RISHIKESH  Department of General Surgery, In patient department ward 353 and 354 And OPD, second floor, AIIMS Rishikesh, VIRBHADRA MARG, RISHIKESH 249203
Dehradun
UTTARANCHAL 
07017662384

ozairkhan321@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AIIMS RISHIKESH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Female 
Details  1.All Female Patients >18 years of age with Biopsy proven Infiltrating Ductal Carcinoma (Adenocarcinoma) Breast
cancer who underwent Modified Radical Mastectomy


2.Giving Informed consent for being included in the study
 
 
ExclusionCriteria 
Details  Preexisting Lymphedema of the Ipsilateral arm.
Axillary Vein thrombosis
Metastatic Breast cancer
Bilateral breast cancer
Recurrent breast cancer
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
To study the Patient factors & Tumour factors as Predictors of Arm Lymphedema in breast cancer patients undergoing Modified Radical Mastectomy
 
To study the Patient factors & Tumour factors as Predictors of Arm Lymphedema in breast cancer patients undergoing Modified Radical Mastectomy

Lymphedema/arm size will be recorded at baseline 1 month, 3 months and 6 months
 
 
Secondary Outcome  
Outcome  TimePoints 
To find the Prevalence of Arm Lymphedema in patients who have undergone Modified Radical Mastectomy.
 
at end of study, 18 months 
Compare prevalence of Arm Lymphedema in patients who have undergone Modified Radical Mastectomy among different stages of Breast cancer.
 
at end of study, 18 months 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
•Sample size: All Breast cancer patients presenting to OPD during the study duration.
•Sample size calculation was done By Fleiss formula with continuity correction and minimum sample size was calculated to be 150
•Study Duration : 18 months
•Study Design : Prospective Observational study
•Data Collection Methods : A structured proforma will be made and demographic and clinical data will be collected at pre defined intervals: 0, 1 and 6 months
•Definition of lymphedema :Post-surgical Arm lymphedema represents the increase of the arm volume over 10% which occurs in the first 3 months after surgical treatment.
 
Close